Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • News
  • Industry Analysis
  • Business Strategy
  • Health Management
  • Hospitals/Providers
  • Pharmacy
  • Technology
  • Topics
MJH Life Sciences

SUBSCRIBE: Print / Digital / eNewsletter

Formulary

Will Outcomes-Based Payments Hit COPD Drugs?

November 29, 2018
  • Michele Meyer

In these arrangements, drug companies must partially reimburse insurers if the drug fails to earn its keep. Will COPD drugs be included in such arrangements?

  • READ >>
four-plans

Will Drug Price Hikes Impact Drug Spending?

November 28, 2018
  • Tracey Walker

Despite a scolding from President Trump over drug price hikes, drug giant Pfizer announced it will raise the prices of 41 medications in January. That’s 10% of its entire drug portfolio.

  • READ >>

Formulary Drug Exclusions on the Rise: What Health Execs Should Know

August 2, 2018
  • Mari Edlin

A 51-year-old female patient has been taking Forteo (teriparatide) for osteoporosis for the past year. Her insurance company notifies her that the drug is no longer on its formulary.

  • READ >>

How Payers are Responding to Growing Orphan Drug Costs

April 26, 2018
  • Aine Cryts

Payers are stepping up efforts to manage the cost and utilization of orphan drug treatments.

  • READ >>

‘Encouraging’ COPD drug pipeline could ease symptoms, address root causes

November 7, 2017
  • Bob Kronemyer

Albert A. Rizzo, MD, senior medical advisor for the American Lung Association, says the increasing number of drugs in the pipeline could improve airflow and address the underlying disease process.

  • READ >>

Survey: How payers use nonpayer generated data to make formulary decisions

October 19, 2017
  • Bryant Furlow

External, non-payer generated data can inform formulary decision-making—if payers know their strengths and weaknesses.

  • READ >>

Three Orphan Drug Program problems and how the FDA plans to fix them

October 11, 2017
  • Karen Appold

Recently, FDA Commissioner Scott Gottlieb announced the FDA will move to close loopholes in the Orphan Drug Program. Here’s what you need to know.

  • READ >>

Expedited FDA approval plays dominant role in drug approvals

March 30, 2017
  • Bryant Furlow

Last year was a banner year for generic drug approvals by the FDA. Find out what’s in store for 2017.

  • READ >>

Top considerations when determining whether to approve expensive drugs

March 30, 2017
  • Bryant Furlow

Weighing the ethics of approving expensive cancer drugs for patients facing terminal disease is a multifaceted endeavor. Here are some recommendations.

  • READ >>

Opinion: More industry-stakeholders play blame game for high drug costs

March 23, 2017
  • Devon Herrick, PhD

Our policy analyst weighs in on a new drug industry PR campaign that attempts to shift the blame for high drug costs.

  • READ >>

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • next ›
  • last »

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • Reimbursement
  • AMCP Street Team
  • AMCP
  • Solid Tumors
  • Non-Hodgkin Lymphoma
3 patient experience questions answered: What 1,500 healthcare professionals revealed about shifting cultural mindset + evolving to meet patient needs
A buyer’s guide to alternative payment models
How adopting a virtual business office delivers new efficiencies to one medical group
Unpredictable pairings: A new approach to community health
Addressing the outsized effect social and economic factors have on health

Current Issue

MHE November 2019
Nov 11, 2019 Vol 29 No 11
Digital Edition
Connect with Us

  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
    • Editorial Board
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".